Sectoral Asset Management’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.16M Buy
61,100
+28,600
+88% +$845K 1.51% 27
2026
Q1
$1.02M Sell
32,500
-12,847
-28% -$330K 0.84% 30
2025
Q4
$984K Sell
45,347
-4,660
-9% -$91.9K 0.79% 36
2025
Q3
$757K Hold
50,007
0.47% 58
2025
Q2
$564K Buy
50,007
+1,100
+2% +$11.9K 0.37% 67
2025
Q1
$493K Buy
48,907
+14,407
+42% +$156K 0.38% 54
2024
Q4
$408K Sell
34,500
-10,627
-24% -$126K 0.27% 60
2024
Q3
$521K Sell
45,127
-830
-2% -$9.45K 0.31% 64
2024
Q2
$486K Sell
45,957
-3,500
-7% -$38.4K 0.2% 66
2024
Q1
$521K Buy
49,457
+13,000
+36% +$140K 0.2% 70
2023
Q4
$409K Buy
36,457
+6,010
+20% +$58.6K 0.18% 84
2023
Q3
$356K Buy
30,447
+5,020
+20% +$56.8K 0.07% 112
2023
Q2
$256K Buy
25,427
+4,427
+21% +$39.6K 0.04% 116
2023
Q1
$155K Hold
21,000
0.03% 114
2022
Q4
$168K Buy
+21,000
New +$117K 0.03% 116

Other funds holding ROIV

Sectoral Asset Management's ROIV Position: Q2 2026 in Review

Sectoral Asset Management increased its Roivant Sciences (ROIV) stake by 88% in Q2 2026, buying an estimated $845K and bringing the position to 61,100 shares worth $2.16M. The position accounts for 1.51% of the portfolio, ranked #27.

Sectoral Asset Management first reported a position in ROIV in Q4 2022 and has held it in 15 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Sectoral Asset Management held 61,100 shares of Roivant Sciences worth $2.16M as of Q2 2026.
  • Sectoral Asset Management bought 28,600 Roivant Sciences shares in Q2 2026, an estimated $845K.
  • Roivant Sciences made up 1.51% of Sectoral Asset Management's portfolio in Q2 2026, its #27 holding.
  • Sectoral Asset Management first reported a position in Roivant Sciences in Q4 2022 and has held it in 15 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Sectoral Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.